IP Library Granted Patent US 8,506,539
Granted Patent B2
US 8,506,539 · App. 11/120,757 · Granted Aug 13, 2013

Eyelid margin wipes comprising chemical means for temperature adjustment

Inventors: Michel Guillon (London, GB); Cecile Adrienne Maissa (London, GB)
Assignee: Optometric Technology Group LTD.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,506,539
App. No.
11/120,757
Granted
Aug 13, 2013
Kind
B2
Abstract

An eyelid margin wipe comprising chemical means for adjusting the temperature of the wipe relative to the ambient temperature. The wipe is particularly useful for treatment of disorders of the eyelid or eyelid margin such as meibomian gland dysfunction.

Claims (31)

1. An eyelid margin wipe for treatment of disorders of an eyelid or eyelid margin comprising: at least two components adapted to change a temperature of the wipe from an ambient temperature upon reaction with each other to an elevated temperature range of from about 40° C. to about 55° C.; a water-impermeable container that prevents the at least two components from coming into contact with a closed eye when in use; a seal for keeping the at least two components separate until temperature change is initiated, wherein the elevated temperature range is reached within 2 minutes after the temperature change is initiated and is maintained for at least 5 minutes without causing damage to a delicate eye region; and at least one agent selected from the group consisting of cleansing agents and surfactant agents, wherein the wipe has a size of one human eye region.

2. The eyelid margin wipe according to claim 1 , wherein the disorder of the eyelid margin is meibomian gland dysfunction.

3. The eyelid margin wipe according to claim 1 , wherein the wipe is sterile.

4. The eyelid margin wipe according to claim 1 , wherein the reaction is an exothermic reaction.

5. The eyelid margin wipe according to claim 1 , wherein the at least two components comprise MgSO 4 and water.

6. The eyelid margin wipe according to claim 1 , wherein the at least two components comprise an inorganic salt and water.

7. The eyelid margin wipe according to claim 1 , wherein the at least two components comprise an oxidising agent and a reducing agent.

8. The eyelid margin wipe according to claim 1 , wherein the temperature is changed to a temperature of from about 40° C. to about 45° C.

9. The eyelid margin wipe according to claim 1 , wherein the temperature is changed to a temperature of from about 45° C. to about 52° C.

10. The eyelid margin wipe according to claim 1 , wherein the elevated temperature is reached within 1 minute.

11. The eyelid margin wipe according to claim 1 , wherein the temperature is maintained at the elevated temperature range for more than 5 minutes.

12. The eyelid margin wipe according to claim 1 , wherein the temperature is maintained at the elevated temperature range for 10 minutes or more.

13. The eyelid margin wipe according to claim 1 , wherein the wipe is square, rectangular, circular or ovoid shaped.

14. The eyelid margin wipe according to claim 1 , wherein the wipe is eye-shaped.

15. The eyelid margin wipe according to claim 1 , wherein the wipe is curved to correspond to a contour of an eye.

16. The eyelid margin wipe according to claim 1 , wherein the wipe is coated with a polymeric material capable of moulding to a surface of the eye.

17. The eyelid margin wipe according to claim 1 , wherein the wipe is coated with a polymeric material which softens at a temperature above ambient temperature, such that, in use, the polymeric material is capable of moulding to the surface of the eye.

18. The eyelid margin wipe according to claim 1 , further comprising at least one active agent.

19. The eyelid margin wipe according to claim 1 , further comprising a drug delivery system.

20. The eyelid margin wipe according to claim 1 , further comprising at least one additional agent selected from the group consisting of antistatic agents, preservatives, antioxidants, antimicrobial agents, chelating agents, emollients, emulsifying agents, buffering/neutralising agents, humectants, thickeners, viscosity controlling agents, antistatic agents, and conditioning agents.

21. The eyelid margin wipe according to claim 20 , wherein the at least one additional agent is incorporated in a thermo-responsive polymer layer coated on a surface of the wipe.

22. The eyelid margin wipe according to claim 20 , wherein the viscosity controlling agent is polyethylene glycol (PEG).

23. The eyelid margin wipe according to claim 20 , further comprising a reflective layer and/or a conductive layer to direct heat towards one surface of the wipe.

24. The eyelid margin wipe according to claim 1 , wherein the at least one agent is comprising a cleansing agent.

25. The eyelid margin wipe according to claim 1 , wherein the at least one agent is a surfactant agent.

26. The eyelid margin wipe according to claim 1 , wherein at least one of the cleansing agent and the surfactant agent is selected from the group consisting of PEG-80 sorbitan laurate, sodium trideceth sulfate, PEG-150 distearate, cocamidopropyl hydroxysultaine, sodium laureth-13 carboxylate, disodium lauroamphodiacetate, polysorbate 80, polysorbate 20, poloxamer 184, ammonium laureth sulfate, ceteareth 20, ceteareth 25, cocamidopropyl betaine, disodium laureth sulfosuccinate, disodium lauriminodipropionate, disodium lauroamphodipropionate, glycol stearate, hydrogenated castor oil, laureth-23, magnesium laureth, oleth sulfate, PEG-20 stearate, PEG-35 castor oil, PEG-40 hydrogenated castor oil, PEG-60 hydrogenated castor oil, PEG-7 hydrogenated castor oil, PEG-75 lanolin, poloxamer, sodium laureth sulfate, sodium trideceth sulfate, sodium C12-15 pareth 15 sulfonate, and sodium C14-16 olefin sulfonate.

27. The eyelid margin wipe according to claim 1 , further comprising an indicator which confirms to a user that a required temperature has been reached.

28. The eyelid margin wipe according to claim 27 , wherein the indicator is a temperature sensitive color indicator configured to change from a first color to a second color when the required temperature has been reached.

29. The eyelid margin wipe according to claim 28 , wherein the indicator is configured to undergo a reversible color change, such that when the wipe is no longer at the required temperature or has fallen outside of a required temperature range, the indicator is configured to revert to the first color.

30. The eyelid margin wipe according to claim 28 , wherein at least a part of the wipe is coated with an indicator selected from the group consisting of a temperature reactive ink and a temperature reactive dye.

31. The eyelid margin wipe according to claim 1 , wherein the seal is a frangible seal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2013
From: GUILLON, MICHEL
To: OPTOMETRIC TECHNOLOGY GROUP LTD.
Reel/Frame 030348/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2013
From: MAISSA, CECILE ADRIENNE
To: GUILLON, MICHEL
Reel/Frame 030348/0759 →
Priority Claims (1)
GB 0225795.4 · Nov 5, 2002 · national
Continuity (2)
Continuation PCTGB0304782 · Nov 5, 2003
Related Publication 20060018953A1 · Jan 26, 2006